NEW YORK, Oct. 15, 2014 /PRNewswire/ -- Lakeland Industries, Inc. (NASDAQ: LAKE) the current stock market selloff over the past month, only two trades have really performed well – the "fear trade" via the Volatility (VIX) Index and the "Ebola trade". According to the Centers for Disease Control (CDC) and the World Health Organization (WHO), there have been approximately 8,400 total cases of Ebola reported in West Africa thus far – resulting in just over 4,000 deaths. Over that time, the so-called "Ebola trade" has largely been characterized by investments in drug manufacturers working on a cure for the disease (i.e. Tekmira, Chimerix, BioCryst, Sarepta, etc.), as well as those who produce protective clothing such as hazmat suits (i.e. Lakeland, Alpha Pro Tech, DuPont, etc.). Given the seriousness of the outbreak, it is no wonder investors have been bidding up shares of any companies associated with the disease.

Lakeland Industries, Inc. (LAKE) manufactures and sells a comprehensive line of safety garments and accessories for the industrial protective clothing market. Among the many products the company offers is their ChemMax product line, which has been heavily promoted throughout the Ebola outbreak given its use among healthcare providers to prevent the spread and transmission of infectious diseases.

The company's product categories include limited use/disposable protective clothing, chemical protective suits, firefighting and heat protective apparel, reusable woven garments, high visibility clothing, and gloves and sleeves. Lakeland's many industrial customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, janitorial, pharmaceutical, and electronics manufacturers, as well as scientific and medical laboratories. In addition, LAKE supplies federal, state and local governmental agencies and departments, such as fire and law enforcement, airport crash rescue units, the Department of Defense, the Department of Homeland Security, and the CDC.  

An in-depth analyst report on LAKE that includes competitive analysis, financial statement analysis, recent price action, discussion of risks and concerns, analyst summary, and recommendation can be viewed by using the following link at no cost:

http://bit.ly/-LAKE-AnalystReport

Copy and paste may be required.

About Small Cap IR

Once you read our reports written by our team of financial analysts you will understand that we make every effort to provide informative equity research reports for interested parties at no cost.

Our Financial Analysts spend countless hours researching stocks. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. These reports include a straightforward assessment of the company by a financial analyst who has pledged to remain free of influence when writing research reports.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. Information in this release is fact checked and produced on a best efforts basis by Michael Anderegg, a CFA charterholder. An outsourced research services provider represented by Michael Anderegg, CFA, provided Small Cap IR this article or report. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. Small Cap IR is not entitled to veto, interfere or alter the articles, documents or report once created and reviewed by the outsourced research provider represented by Michael Anderegg, CFA.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at admin@smallcapir.com. For any urgent concerns or inquiries, please contact us at admin@smallcapir.com.

NOT FINANCIAL ADVICE

Small Cap IR and BrokerBank Securities, Inc. make no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Small Cap IR and BrokerBank Securities, Inc. are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. Small Cap IR has compensated Michael Anderegg, CFA, for the right to disseminate analyst report. No liability is accepted by Small Cap IR and BrokerBank Securities, Inc. whatsoever for any direct, indirect or consequential loss arising from the use of this document. Small Cap IR expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Small Cap IR and BrokerBank Securities, Inc. do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

SOURCE Small Cap IR